DARE: Several Important Milestones, Including Ovaprene PCT Read-Out, Anticipated Later This Year - Yahoo Finance

DARE: Several Important Milestones, Including Ovaprene PCT Read-Out, Anticipated Later This Year  Yahoo Finance

R&D expense, including license fees, was $1.8M, compared to $1.2M and $1.9M in the prior-year and three-month periods, respectively. We note that Q1 ...



Comments

Popular posts from this blog

How to Deal with Vaginal Infections and Vaginal Atrophy After Menopause

Shave your pubic hair if you want, but not at these times